Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Capricor Second Quarter 2017 Update Webcast And Conference Call Scheduled For Thursday, August 10 August 3, 2017 Blake Insomnia Therapeutics Announces Submitting Clinical Trial Application For Phase II Clinical Testing August 24, 2017 UK's Dechra Spends $422.1M on Two Dutch Animal Pharmas January 24, 2018
Capricor Second Quarter 2017 Update Webcast And Conference Call Scheduled For Thursday, August 10 August 3, 2017
Blake Insomnia Therapeutics Announces Submitting Clinical Trial Application For Phase II Clinical Testing August 24, 2017
